Hengrui Presents 64 Oncology Research Studies at ESMO Congress
Hengrui said it presented 64 research studies at the 2026 ESMO Congress, highlighting its oncology research and development work.
Related stories
H2O America Prices Equity Unit Offering
H2O America announced pricing of an offering of equity units.
M impact | EQUITY | Oct 30, 2026, 03:37 AM UTC
Two Point Zero Group Reports Quarterly Revenue of AED 11.84 Billion
M impact | EQUITY | Oct 30, 2026, 03:35 AM UTC
Two Point Zero Group Reports Quarterly Profit of AED 1.51 Billion
M impact | EQUITY | Oct 30, 2026, 03:34 AM UTC
Axis Trustee Gives Yes Bank Three Days to Restore Rs.8,415 Crore AT1 Bonds
Axis Trustee Services has asked Yes Bank to reinstate Rs.8,415 crore of AT1 bonds written off in 2020, following a Supreme Court ruling restoring the bonds. The trustee also sought
M impact | EQUITY | Oct 30, 2026, 03:34 AM UTC
South Korea’s Kospi Falls More Than 5% at the Open
The Kospi fell more than 5% at the open after declines on Wall Street.
M impact | EQUITY | Oct 30, 2026, 03:34 AM UTC
Nikkei Down 2.5% After BOJ Decision
Japan's Nikkei share average was last down 2.5%, described as largely unmoved by the BOJ decision.
M impact | EQUITY | Oct 30, 2026, 03:31 AM UTC